| PFE Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the PFE market cap history going back to 2/18/2010:
Also see: PFE Shares Outstanding History and PFE YTD Return |
PFE Market Cap History — Pfizer Capitalization Over Time
As of 7/29/2026 Pfizer has a market cap of 35.33 billion. Investors often follow the PFE market cap history to compare the size of the company over time.
This page shows PFE market capitalization trends over time, with 67 market cap datapoints presented, dating back to 2/18/2010.
| PFE Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PFE Historical Market Cap: -8.15% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PFE Stock Price Chart |
| About Pfizer Inc |
| Pfizer Inc. is a research-based global biopharmaceutical company. Co. is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. We show 67 historical shares outstanding datapoints in our PFE shares outstanding history coverage, used to compute PFE market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing PFE market cap history over the course of time is important for investors interested in comparing PFE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of PFE versus a peer is one thing; comparing PFE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like PFE can fluctuate over the course of history. With this page we aim to empower investors researching PFE by allowing them to research the PFE market cap history. |
| PFE Current Stock Quote |
Quotes delayed 20 minutes  Free PFE Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| PFE Share Performance |
| Market Cap Peers |
| Pfizer (PFE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
PGEN Market Cap History PGNX Market Cap History PGNY Market Cap History PHAS Market Cap History PHAT Market Cap History PHIO Market Cap History PIII Market Cap History PIRS Market Cap History PKI Market Cap History PLRX Market Cap History More Healthcare companies » |
PFE Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
